Kairos Pharma Files 8-K Current Report
Kairos Pharma, LTD. (KAPA) filed a Form 8-K Current Report with the U.S. Securities and Exchange Commission on October 6, 2026. The 8-K filing is used to announce material events that shareholders should know about.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.